FDA Inspection 840133 — Kentucky Blood Center Inc

Kentucky Blood Center Inc — FEI 1070402

The FDA completed an inspection of Kentucky Blood Center Inc on July 12, 2013 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 12, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lexington, KY (United States)

Citations

IDCFRDescription
63021 CFR 803.17Lack of Written MDR Procedures
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs